In this article
Check out the companies making headlines before the bell:
Anthem (ANTM) — The health insurer reported adjusted quarterly profit of $6.79 per share, beating the $6.37 per share consensus estimate from Refinitiv, with revenue also topping forecasts. Anthem also raised its full-year outlook amid higher premiums for its Medicare and Medicaid businesses.
Biogen (BIIB) — The drug maker's stock rose 2.2% in the premarket after the company beat estimates on the top and bottom lines and raised its full year forecast. Biogen earned an adjusted $4.77 per share for the quarter, compared with a consensus estimate of $4.11 per share. The company is still optimistic about prospects for its Alzheimer's drug Aduhelm, despite slower than expected adoption.